Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1998
12/22/1998US5852047 Pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
12/22/1998US5852044 Use of NK1 receptor antagonists for preparing cardio-regulatory drugs
12/22/1998US5852043 HIV protease inhibitors
12/22/1998US5852040 Neuroprotective 3,4-dihydro-2(1H)-quinolone compounds
12/22/1998US5852039 Pharmaceutical composition containing quinoline or quinazoline derivatives
12/22/1998US5852037 Method for treating anxiety
12/22/1998US5852036 Method for treating anxiety
12/22/1998US5852035 Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines
12/22/1998US5852034 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
12/22/1998US5852033 Methods of treatment using lamellarin-class alkaloids
12/22/1998US5852032 Method of treating nicotine dependence
12/22/1998US5852031 2,7-substituted octahydro-1H-pyrido 1,2-a!pyrazine derivatives
12/22/1998US5852024 Treatment and prevention of adhesions
12/22/1998US5852022 Antipsychotic agents, composition and method of use
12/22/1998US5852021 Polymorph B of 1-(diphenylmethyl)-4- 3-(2-phenyl-1,3-dioxolan-2-YL) propyl! piperazine
12/22/1998US5852020 Nefazodone: use in treating post traumatic stress disorder
12/22/1998US5852017 2,3(1H,4H)-quinoxalinediones
12/22/1998US5852016 Quinoxaline derivatives useful in therapy
12/22/1998US5852014 Condensed indole derivatives as 5HT4 -receptor antagonists
12/22/1998US5852009 Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon
12/22/1998US5852007 Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same
12/22/1998US5852005 Tetracyclic triterpenes
12/22/1998US5852004 Drug and pharmaceutical composition for the treatment of lesions of the digestive tract
12/22/1998US5852003 Drug and pharmaceutical composition for the treatment of muscles
12/22/1998US5852002 Treatment of conditions and disease
12/22/1998US5851999 FLK-1 is a receptor for vascular endothelial growth factor
12/22/1998US5851996 Materials and methods for treatment of plaquing diseases
12/22/1998US5851992 Treatment of growth hormone deficiency
12/22/1998US5851989 Method of extending the plasma half-life of vascular endothelial cell growth factor
12/22/1998US5851978 Soap composition
12/22/1998US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus
12/22/1998US5851806 Complementary adenoviral systems and cell lines
12/22/1998US5851800 Process for producing a protein
12/22/1998US5851786 Product and process to regulate actin polymerization
12/22/1998US5851784 Human phosphodiesterase type IVC, and its production and use
12/22/1998US5851782 Inhibitors of ceramidase
12/22/1998US5851775 β-catenin, Tcf-4, and APC interact to prevent cancer
12/22/1998US5851555 Controlled release dosage forms containing water soluble drugs
12/22/1998US5851551 Sustained-release matrices for dental application
12/22/1998US5851550 Pharmaceutical formulations of compacted granulates of β-Lactam antibiotics
12/22/1998US5851543 Skin care preparation and method
12/22/1998US5851540 Composition, barrier film, and method for preventing contact dermatitis
12/22/1998US5851538 Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
12/22/1998US5851537 Topical application of α-DFMO for preventing skin cancer
12/22/1998US5851526 Methods of treating colon cancer utilizing tumor-specific antibodies
12/22/1998US5851518 Polymeric compositions
12/22/1998US5851513 Antiplaque oral composition and method
12/22/1998CA2126699C An iron-containing composition for the prevention of anaemia and a method for producing the composition
12/22/1998CA2103826C 17-(3-furyl) and 17-(4-pyridazinyl) -5.beta.,14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
12/22/1998CA2071955C Reduced-protein subunit vaccine for swine dysentery
12/22/1998CA2059363C Benzo¬5,6|cyclohepta¬1,2-b|pyridine derivatives and antiallergic agents comprising same
12/22/1998CA2008775C Nail lacquer
12/22/1998CA2001201C Antimicrobial quinolonyl lactams esters
12/22/1998CA1340286C Pt(iv) complexes
12/22/1998CA1340285C Novel quinolonecarboxylic acid derivatives having at 7-position a piperidin-1-yl substituent
12/20/1998CA2235442A1 Response regulator
12/20/1998CA2235441A1 Novel compounds
12/20/1998CA2235433A1 Novel compounds
12/18/1998CA2240871A1 Therapeutic agent for rheumatic disease comprising nonsteroidal anti-inflammatory drug and phenylpropionic acid derivative
12/18/1998CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998WO1998057176A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents
12/17/1998WO1998057175A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma
12/17/1998WO1998056941A1 Carbohydrate complex extracted from mycobacterium tuberculosis and process for the preparation thereof
12/17/1998WO1998056907A1 Heart and skeleton muscle specific nucleic acid, the production and use thereof
12/17/1998WO1998056883A1 WAX ESTERS ENRICHED IN φ-3 UNSATURATED FATTY ACIDS, THEIR PREPARATION AND THEIR USE
12/17/1998WO1998056829A1 Method for fixing or separating ions, in particular of lead, using per(3,6-anhydro) cyclodextrin derivatives
12/17/1998WO1998056828A1 Method for manufacturing pure guar meal
12/17/1998WO1998056820A1 Hm74a receptor
12/17/1998WO1998056812A2 Estrogen receptor crystals and ligands
12/17/1998WO1998056802A1 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
12/17/1998WO1998056801A1 C-4''-substituted macrolide derivatives
12/17/1998WO1998056800A1 9-oxime erythromycin derivatives
12/17/1998WO1998056793A1 3-substituted pyrido [3',4':4,5] thieno [2,3-d] pyrimidine derivatives, and production and use of the same
12/17/1998WO1998056792A1 3-substituted 3,4 dihydro-thieno[2, 3-d]pyrimidine derivatives and production and use of the same
12/17/1998WO1998056788A1 Imidazolyl-cyclic acetals
12/17/1998WO1998056787A1 4-Phenylpiperidine compounds
12/17/1998WO1998056786A1 2-aminoalkylaminoquinolines as dopamine d4 ligands
12/17/1998WO1998056783A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
12/17/1998WO1998056773A1 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic
12/17/1998WO1998056772A1 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3--triazole-4-carboxamide and its use as antiepileptic
12/17/1998WO1998056771A2 Piperazine derivatives and their use as anti-inflammatory agents
12/17/1998WO1998056768A1 Tricyclic pyrrole or pyrazole derivatives
12/17/1998WO1998056761A2 Benzimidazole derivatives
12/17/1998WO1998056759A2 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
12/17/1998WO1998056717A1 Improved method for preparing low-concentration polyaluminosilicate microgels
12/17/1998WO1998056424A1 Biologically active materials
12/17/1998WO1998056422A1 Polar drug or prodrug compositions with extended shelf-life storage and a method of making thereof
12/17/1998WO1998056420A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998WO1998056408A2 Inhibitors of microbial adherence or invasion as therapeutic agents and broad-spectrum enhancers of antibiotic therapy
12/17/1998WO1998056407A2 Fibronectin antagonists as therapeutic agents and broad-spectrum enhancers of antibiotic therapy
12/17/1998WO1998056397A1 Weight control composition comprising hypericum perforatum
12/17/1998WO1998056392A1 INHIBITORS OF β-LACTAMASES AND USES THEREFOR
12/17/1998WO1998056390A1 Anthelmintic compositions
12/17/1998WO1998056389A1 Prevention of ovarian cancer by administration of a vitamin d compound
12/17/1998WO1998056388A1 Vitamin d-containing preventives and/or remedies for conjunctival/corneal xerosis
12/17/1998WO1998056387A1 Method of treatment of liver tumours and pharmaceutical compositions for use therein
12/17/1998WO1998056386A1 A medicament useful for the treatment of post-menopausal syndrome and osteoporosis, and for reducing fat mass and increasing lean body mass
12/17/1998WO1998056383A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998WO1998056382A1 Topical application of opioids for treatment of acne and other inflammatory conditions
12/17/1998WO1998056381A1 Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
1 ... 6564 6565 6566 6567 6568 6569 6570 6571 6572 6573 6574 6575 6576 6577 6578 6579 6580 6581 6582 6583 6584 ... 7860